![Immunodominant MHC-II (Major Histocompatibility Complex II) Restricted Epitopes in Human Apolipoprotein B | Circulation Research Immunodominant MHC-II (Major Histocompatibility Complex II) Restricted Epitopes in Human Apolipoprotein B | Circulation Research](https://www.ahajournals.org/cms/asset/aaeb2292-737e-43af-a29d-9c6d7556154d/circresaha.122.321116.fig09.jpg)
Immunodominant MHC-II (Major Histocompatibility Complex II) Restricted Epitopes in Human Apolipoprotein B | Circulation Research
![Characterization of Drug-Specific CD4+ T-Cells Reveals Possible Roles of HLA Class II in the Pathogenesis of Carbamazepine Hypersensitivity Reactions | Chemical Research in Toxicology Characterization of Drug-Specific CD4+ T-Cells Reveals Possible Roles of HLA Class II in the Pathogenesis of Carbamazepine Hypersensitivity Reactions | Chemical Research in Toxicology](https://pubs.acs.org/cms/10.1021/acs.chemrestox.2c00414/asset/images/medium/tx2c00414_0004.gif)
Characterization of Drug-Specific CD4+ T-Cells Reveals Possible Roles of HLA Class II in the Pathogenesis of Carbamazepine Hypersensitivity Reactions | Chemical Research in Toxicology
![HLA‑mediated tumor escape mechanisms that may impair immunotherapy clinical outcomes via T‑cell activation (Review) HLA‑mediated tumor escape mechanisms that may impair immunotherapy clinical outcomes via T‑cell activation (Review)](https://www.spandidos-publications.com/article_images/ol/14/4/ol-14-04-4415-g02.jpg)
HLA‑mediated tumor escape mechanisms that may impair immunotherapy clinical outcomes via T‑cell activation (Review)
![Variations in HLA-B cell surface expression, half-life and extracellular antigen receptivity | eLife Variations in HLA-B cell surface expression, half-life and extracellular antigen receptivity | eLife](https://iiif.elifesciences.org/lax/34961%2Felife-34961-fig9-v1.tif/full/1500,/0/default.jpg)
Variations in HLA-B cell surface expression, half-life and extracellular antigen receptivity | eLife
![Frontiers | HLA Class I Molecules as Immune Checkpoints for NK Cell Alloreactivity and Anti-Viral Immunity in Kidney Transplantation Frontiers | HLA Class I Molecules as Immune Checkpoints for NK Cell Alloreactivity and Anti-Viral Immunity in Kidney Transplantation](https://www.frontiersin.org/files/Articles/680480/fimmu-12-680480-HTML/image_m/fimmu-12-680480-g001.jpg)
Frontiers | HLA Class I Molecules as Immune Checkpoints for NK Cell Alloreactivity and Anti-Viral Immunity in Kidney Transplantation
![Human Leukocyte Antigen (HLA) Typing and Stem Cell Harvesting: Information for Donors | Memorial Sloan Kettering Cancer Center Human Leukocyte Antigen (HLA) Typing and Stem Cell Harvesting: Information for Donors | Memorial Sloan Kettering Cancer Center](https://www.mskcc.org/sites/default/files/patient_ed/human_leukocyte_antigen_hla_typing_and_stem_cell_collection_information_for_donors-129784/hla_markers-en.png)
Human Leukocyte Antigen (HLA) Typing and Stem Cell Harvesting: Information for Donors | Memorial Sloan Kettering Cancer Center
![Abrogation of HLA surface expression using CRISPR/Cas9 genome editing: a step toward universal T cell therapy | Scientific Reports Abrogation of HLA surface expression using CRISPR/Cas9 genome editing: a step toward universal T cell therapy | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-74772-9/MediaObjects/41598_2020_74772_Fig1_HTML.png)
Abrogation of HLA surface expression using CRISPR/Cas9 genome editing: a step toward universal T cell therapy | Scientific Reports
![Novel TCR-like CAR-T cells targeting an HLA∗0201-restricted SSX2 epitope display strong activity against acute myeloid leukemia: Molecular Therapy - Methods & Clinical Development Novel TCR-like CAR-T cells targeting an HLA∗0201-restricted SSX2 epitope display strong activity against acute myeloid leukemia: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/asset/d0c2375e-3707-421a-b57f-e7f31cf78873/fx1.jpg)
Novel TCR-like CAR-T cells targeting an HLA∗0201-restricted SSX2 epitope display strong activity against acute myeloid leukemia: Molecular Therapy - Methods & Clinical Development
![Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry - Freudenmann - 2018 - Immunology - Wiley Online Library Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry - Freudenmann - 2018 - Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/04bdee40-bc61-4d23-b36c-13cd8220d591/imm12936-fig-0001-m.jpg)